Axsome Therapeutics, Inc. Total 2Q 2024 net product revenue of $87.2 million, representing 87% year-over-year growth Auvelity® 2Q 2024 net product sales of $65.0 million, representing...
Another reminder: Our sale on a Business Insider subscription ends Thursday. More details here. But first, send me your résumé. If this was forwarded to you,...